4.8 Article

Plasmonic modulation of gold nanotheranostics for targeted NIR-II photothermal-augmented immunotherapy

期刊

NANO TODAY
卷 35, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2020.100987

关键词

Gold nanotheranostics; DNA template; Second near-infrared window; Photothermal therapy; Immunotherapy

资金

  1. Guangdong Province Natural Science Foundation of Major Basic Research and Cultivation Project [2018B030308003]
  2. Basic Research Program of Shenzhen [JCYJ20170412111100742, JCYJ20180305163452667, JCYJ20180507182413022]
  3. Shenzhen Science and Technology Program [KQTD20190929172538530]
  4. National Natural Science Foundation of China [82071985, 21874119, 81903564, 31771036, 51703132]
  5. Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [161032]
  6. National Key Research and Development Program of China [2018YFA0704000, 2020YFC2004600, 2017YFE0100200]

向作者/读者索取更多资源

Cancer phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) has low tissue scattering and high permissive laser exposure. However, most of the few available theranostic agents in this spectral region suffer from thermal instability and poor programmability of absorption profiles. Here, we proposed a programmable method for the plasmonic modulation of gold nanotheranostics in the NIR-II window. By adjusting the sequences and concentrations of DNA templates, the localized surface plasmon resonance (LSPR) of gold theranostics successfully redshifts to the NIR-II window. The asprepared gold nanodumbbells (AuNDs) possess good thermal stability, strong photoacoustic (PA) signals as well as high photothermal conversion efficiency (84.9 %). After conjugation with nucleolin-targeted DNA aptamer AS1411, the obtained targeted gold nanotheranostics (denoted as Ap-AuND) could perform effective NIR-II PA imaging-guided PTT for subcutaneous 4T1 tumors. Notably, the Ap-AuND-mediated NIR-II PTT significantly suppressed tumor growth and stimulated potent host antitumor immunity, resulting in significant inhibition of both distant tumor growth and whole-body spreading of tumor cells when combined with an anti-PDL1 antibody. (C) 2020 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据